| ASD | Autism spectrum disorder |
| CAM | Complementary and alternative medicine |
| ROS | Reactive oxygen species |
| PDDs | Pervasive developmental disorders |
| AAs | Amino acids |
| AS | Asperger’s syndrome |
| NMDA | N-methyl D-aspartate |
| NO | Nitric oxide |
| BBB | blood–brain barrier |
| MDA | Malondialdehyde |
| DHA | Docosahexaenoic acid |
| ALA | Alpha-linolenic acid |
| EPA | Eicosapentaenoic acid |
| NF-κB | Nuclear factor kappa B |
| PI3K | Phosphatidylinositol 3-Kinase |
| RCTs | Randomized controlled trials |
| BDNF | Brain-derived neurotrophic factor |
| COX | Cyclooxygenase |
| PPARs | Peroxisome proliferator-activated receptors |
| eNOS | Endothelial nitric oxide synthase |
| SIRT1 | Sirtuin (silent mating type information regulation homolog 1) |
| AMPK | AMP-activated protein kinase |
| RSV | Resveratrol |
| VPA | Valproic acid |
| PVC | Parvalbumin |
| PPA | Propionic acid |
| MMP-9 | Matrix metalloproteinase-9 |
| SD | Schizotypal disorder |
| NAR | Naringenin |
| VLDL | Very low-density lipoproteins |
| MCAO | Middle cerebral artery occlusion |
| SOCS3 | Suppressor of cytokine signaling 3 |
| NRF2 | Nuclear factor erythroid 2–related factor 2 |
| CGA | Clinical Global Assessment |
| ABC | Autism Behavior Checklist |
| SRS | Social Responsiveness Scale |
| GSH-Px | Glutathione peroxidase |
| SOD | Superoxide dismutase |
| MPO | Myeloperoxidase |
| ETC | Electron transport chain |
| GI | Gastrointestinal |
| RDBPC | Randomized Double Blind Placebo Control |
| PedPRM | Pediatric-appropriate prolonged-release melatonin |
| RRBs | Restricted and repetitive behaviors |
| IMFAR | International Meeting for Autism Research |
| SRS | Social Responsiveness Scale |
| CBD | Cannabidiol |
| THC | Tetrahydrocannabinol |
| GABAA | Gamma-Aminobutyric Acid-A |
| AEA | N-arachidonoylethanolamine (anandamide) |
| ECS | Endocannabinoid system |
| CNS | Central nervous system |
| DAGL | Diacylglycerol lipase |
| 2-AG | 2-arachidonoylglycerol |
| FXS | Fragile X Syndrome |
| CBDV | Cannabidavarin |
| ADAMS | Anxiety, Depression, and Mood Scale |
| FDA | Food and Drug Administration |
| SCFAs | Short-chain fatty acids |
| Mg | Magnesium |
| PD | Parkinson’s disease |